Images List Premium Download Classic

Nicotinamide

Nicotinamide-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Amido thiadiazole derivatives as nadph oxidase inhibitors
Genkyotex Suisse Sa
December 07, 2017 - N°20170348296

The present invention is related to amino thiazole derivatives of formula (i), pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to nicotinamide adenine dinucleotide phosphate oxidase (nadph oxidase).
Compositions, methods and kits for reducing lipid levels
Nusirt Sciences, Inc.
November 30, 2017 - N°20170340615

Compositions, methods, and kits useful for treating hyperlipidemic conditions are provided herein. Such compositions can contain synergizing amounts of nicotinic acid, nicotinamide riboside and/or nicotinic acid metabolites in combination with leucine and/or a leucine metabolite, with or without resveratrol.
Methods for treating cancer
Nusirt Sciences, Inc.
November 02, 2017 - N°20170312300

The invention relates to nicotinamide riboside or a derivative thereof for use in the treatment and/or prevention of liver or pancreatic cancer in a subject. Additionally, the invention relates to an in vitro method for designing a customized therapy for a subject diagnosed with a liver cancer or pancreatic cancer or suffering early signs of chronic liver damage or ...
Nicotinamide Patent Pack
Download + patent application PDFs
Nicotinamide Patent Applications
Download + Nicotinamide-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Nicotinamide-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Use of nicotinic acid riboside or nicotinamide riboside derivatives, and reduced derivatives thereof, as nad+ ...
Chromadex Inc.
October 26, 2017 - N°20170304338

Compositions are provided including nicotinic acid riboside (“nar”), and derivatives thereof including 1-(2′,3′,5′-triacetyl-beta-d-ribofuranosyl)-nicotinic acid (“nar triacetate” or “narta”); or derivatives of a reduced form of nicotinic acid riboside (“narh”), including 1-(2′,3′,5′-triacetyl-beta-d-ribofuranosyl)-1,4-dihydronicotinic acid (ȁ...
Combined anticancer drug sensitivity-determining marker
Chromadex Inc.
October 19, 2017 - N°20170299597

The anti-cancer agent sensitivity determination marker, the anti-cancer agent including oxaliplatin or a salt thereof and fluorouracil or a salt thereof, contains one or more substances selected from among an amino-acid-metabolism-related substance, a nucleic-acid-metabolism-related substance, a substance in the pentose phosphate pathway, a substance in the glycolytic pathway, a substance in the tca cycle, a polyamine-metabolism-related substance, 7,8-dihydrobiopterin, 6-phosphogluconic acid, ...
Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucleotide, reduced nicotinyl compounds, and nicotinoyl ...
Chromadex Inc.
October 19, 2017 - N°20170296564

Methods for delivering at least one compound selected from nicotinamide riboside (nr), nicotinic acid riboside (nar), and nicotinamide mononucleotide (nmn), derivatives thereof, or salts thereof, in combination with at least one of thiamine (vitamin b1), riboflavin (vitamin b2), niacin (vitamin b3), and pyridoxine (vitamin b6), to an infant human subject in need of said compound or compounds are provided.
Nicotinamide Patent Pack
Download + patent application PDFs
Nicotinamide Patent Applications
Download + Nicotinamide-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Nicotinamide-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Skin care and cosmetic composition
Infinitus (china) Company Ltd.
October 05, 2017 - N°20170281988

A skin care composition and product having beneficial effects on skin conditions/symptoms, such as reducing wrinkles and skin roughness and improving skin elasticity, etc. The composition has three separate parts: a powder part, an aqueous part and an emulsion part. The power part comprises oligopeptide-1 and ginseng saponin. The aqueous part comprises glycyrrhiza glabra root extract, artemisia capillaris flower ...
6-(5-hydroxy-1h-pyrazol-1-yl)nicotinamide inhibitors of phd
Infinitus (china) Company Ltd.
September 28, 2017 - N°20170275271

Which are useful as inhibitors of phd, pharmaceutical compositions thereof, methods for treatment of conditions associated with hif, processes for making the compounds and intermediates thereof.
Use of beta-nicotinamide mononucleotide in preparation of anti-aging drugs or health-care products
Bontac Bio-engineering (shenzhen) Co., Ltd
September 21, 2017 - N°20170266213

Disclosed is use of β-nicotinamide mononucleotide in the preparation of anti-aging drugs or health-care products. A single dose of the β-nicotinamide mononucleotide is 1-500 mg/kg body weight/day, and the drug or health-care product is in the form of tablets, capsules, granules, aqueous solutions, enteric-coated preparations or injections.
Methods for preparing tire treads with advantageous wear characteristics
Bridgestone Americas Tire Operations, Llc
August 31, 2017 - N°20170247530

A method for preparing a vulcanizable composition of matter, the method comprising mixing rubber, silica, silica coupling agent, a strong base, and nicotinamide to form a masterbatch, introducing a curative to the masterbatch, and mixing the curative into the masterbatch to form a vulcanizable composition of matter.
Methods for preparing tire treads with advantageous wear characteristics
Bridgestone Americas Tire Operations, Llc
August 17, 2017 - N°20170233558

A method for preparing a vulcanizable composition of matter, the method comprising mixing, within a first mixing step, rubber, silica, and silica coupling agent to form a first masterbatch composition, adding nicotinamide to the first masterbatch composition and mixing within a second mixing step to form a second masterbatch composition, and adding a curative to the second masterbatch composition and ...
Nicotinamide adenine dinucleotide indicators, methods of preparation and application thereof
East China University Of Science And Technology
August 03, 2017 - N°20170219584

The invention relates to a genetically encoded fluorescent sensor for nicotinamide adenine dinucleotide, as well as methods of preparation and uses thereof. In one aspect, this invention relates to a sensor for detecting nicotinamide adenine dinucleotide, particularly, a recombinant fluorescent fusion protein sensor for detecting nicotinamide adenine dinucleotide. In one specific aspect, this invention relates to a recombinant fluorescent fusion ...
Nicotinamide Patent Pack
Download + patent application PDFs
Nicotinamide Patent Applications
Download + Nicotinamide-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Nicotinamide-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Preparation and use of crystalline beta-d-nicotinamide riboside
Glaxosmithkline Intellectual Property (no.2) Limited
July 20, 2017 - N°20170204131

Provided herein are crystalline beta-d-nicotinamide riboside chloride compositions and methods of preparation and use thereof. Also provided are related pharmaceutical compositions and methods of use thereof. The crystalline beta-d-nicotinamide riboside chloride compositions may be used to treat a disease or disorder that would benefit from increased nad levels including a mitochondrial disease or disorder, insulin resistance, a metabolic syndrome, diabetes, ...
4,5-dihydroisoxazole derivatives as nampt inhibitors
Aurigene Discovery Technologies Limited
July 20, 2017 - N°20170204092

The present invention provides 4,5-dihydroisoxazole derivatives of formula (i), which may be therapeutically useful, more particularly as nampt inhibitors. Wherein, ring a, l1, l2, x1, x2, x3, z, r1, r2, r3, r4, r5, m, n, p and q have the meanings given in the specification and pharmaceutically acceptable salts thereof that are useful in the treatment and prevention of diseases ...
Compositions and methods for treating hyperproliferative epidermal diseases
Dermipsor Ltd.
July 13, 2017 - N°20170196897

The present invention provides compositions and methods for use in the treatment of hyperproliferative dermal diseases. Specifically, the present invention teaches pharmaceutical compositions for topical administration that include a vitamin d metabolite, calcipotriol, and nicotinamide in a combination that is particularly effective in treating and in the maintenance therapy of psoriasis and other related dermal disorders and diseases.
Nicotinamide mononucleotide derivatives and their uses
Dermipsor Ltd.
July 06, 2017 - N°20170189434

The invention relates to compositions of nicotinamide mononucleotide derivatives and their methods of use. The invention also relates to methods of preparing nicotinamide mononucleotide derivatives. The invention relates to pharmaceutical compositions and nutritional supplements containing a nicotinamide mononucleotide derivative. The invention relates to methods of using nicotinamide mononucleotide derivatives that promote the increase of intracellular levels of nicotinamide adenine dinucleotide (...
Nicotinamide riboside analogs and pharmaceutical compositions and uses thereof
Dermipsor Ltd.
July 06, 2017 - N°20170189433

Wherein r1 is —c(═o)—x—(c2-c18 straight chain or branched) alkyl or —c(═o)—x—(c2-c18 straight chain or branched) alkenyl; each r2 is independently selected from hydrogen, and a —c(o)—x—(c1-c18 straight chain or branched) alkyl or a —c(o)—...
Form a of mesylate for nicotinamide derivatives and preparation method and application thereof
Shanghai Suntrong Biotechnology Co., Ltd.
June 29, 2017 - N°20170183310

The invention discloses a form a of mesylate for nicotinamide derivatives and preparation method and application thereof, wherein the xrpd pattern of the form a of mesylate for nicotinamide derivatives has a diffraction peak at 2θ=5. 34, 10. 341, 14. 438, 15. 841, 17. 32, 18. 301, 18. 68, 19. 005, 19. 577, 20. 26, 21. 161, 21. 859, 22. 379, 23. 04, 23. 5, 24. 177, 24. 959, 25. 881, 26. 641, 27. 18, 28. 3, 28. 999, 29. 501, 31. 96, 32. 258, 33. 999, 36. 798, 37. 38 and 41. 297 with the error range of the 2θ values being ±0. 2. The form a of mesylate for nicotinamide derivatives provided by the ...
Hydrazino 1h-imidazoquinolin-4-amines and conjugates made therefrom
3m Innovative Properties Company
June 22, 2017 - N°20170173164

1h-imidazo[4,5-c]quinolin-4-amines substituted at the 1-position with a substituent bearing a hydrazinobenzamide or hydrazinonicotinamide, a salt thereof, or a protected hydrazinobenzamide or hydrazinonicotinamide and conjugates made from such compounds are disclosed. Pharmaceutical compositions containing the compound or the conjugate, methods of making a conjugate, and methods of use of the compounds or conjugates as immunomodulators for inducing cytokine ...
Use of beta-nicotinamide mononucleotide in preparation of health-care products for preventing and treating arteriosclerosis and ...
Bontac Bio-engineering (shenzhen) Co., Ltd
June 15, 2017 - N°20170165283

A health care product having nicotinamide mononucleotide as the active ingredient, and the use of nicotinamide mononucleotide in preparing health care products for the prevention and treatment of arteriosclerosis and cardiovascular and cerebrovascular diseases caused by arteriosclerosis.
Loading